Abstract
AbstractFew clinical solutions exist for cardiac fibrosis, creating the need for a tunablein vitromodel to better understand fibrotic disease mechanisms and screen potential therapeutic compounds. Here, we combined cardiomyocytes, cardiac fibroblasts, and exogenous extracellular matrix (ECM) proteins to create an environmentally-mediatedin vitrocardiac fibrosis model. Cells and ECM were combined into 2 types of cardiac tissues-aggregates and tissue rings. The addition of collagen I had a drastic negative impact on aggregate formation, but ring formation was not as drastically affected. In both tissue types, collagen and other ECM did not severely affect contractile function. Histological analysis showed direct incorporation of collagen into tissues, indicating that we can directly modulate the cells’ ECM environment. This modulation affects tissue formation and distribution of cells, indicating that this model provides a useful platform for understanding how cells respond to changes in their extracellular environment and for potential therapeutic screening.
Publisher
Cold Spring Harbor Laboratory
Reference41 articles.
1. Pagliarosi O , Picchio V , Chimenti I , Messina E , Gaetani R. Building an Artificial Cardiac Microenvironment: A Focus on the Extracellular Matrix. Front Cell Dev Biol [Internet]. 2020 Sep 4 [cited 2020 Oct 6];8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500153/
2. Multicellular 3D Models for the Study of Cardiac Fibrosis;Int J Mol Sci,2022
3. Bearing My Heart: The Role of Extracellular Matrix on Cardiac Development, Homeostasis, and Injury Response;Front Cell Dev Biol,2021
4. The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis;J Cardiovasc Dev Dis,2019
5. Cardiac fibrosis – A short review of causes and therapeutic strategies